SCHEMBL4480243

SCHEMBL4480243

Cc1cc(=O)c(-c2ccc(-c3ccc4c(c3)OCO4)nc2)c(C)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.47
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 4/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 5/20 0.41
HSD17B10 Q99714 3/20 0.41
NPC1 O15118 3/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALOX5 P09917 1/20 0.39
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39
PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13754689 0.82 BRD4 (0.47) BRD4KDM4EALDH1A1POLBPKM
SCHEMBL13754690 0.82 BRD4 (0.45) BRD4KDM4EALDH1A1POLBPKM
SCHEMBL4468273 0.80 ALDH1A1 (0.45) BRD4KDM4EALDH1A1POLBHPGD
SCHEMBL13754678 0.79 HPGDS (0.48) KDM4EALDH1A1HPGDMAPTL3MBTL1
SCHEMBL4480239 0.76 BRD4 (0.47) BRD4KDM4EALDH1A1POLBPKM
SCHEMBL3395824 0.75 KDM1A (0.40) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL13761994 0.75 MAPT (0.43) KDM4EMAPTRAB9AL3MBTL1IDO1
SCHEMBL15759173 0.74 ALDH1A1 (0.57) KDM4EALDH1A1POLBPKMHPGD
SCHEMBL4486775 0.74 SLC2A1 (0.46) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4478658 0.72 MAT2A (0.40) ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP BRD4 2655/4885KDM4E 1311/4885ALDH1A1 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.